TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an agreement with Tasman Pharma, Inc. (Tasman), it has commenced sales and distribution of Versacloz™ Brand (Clozapine, USP) Oral Suspension, 50mg/mL. Tasman recently acquired the approved NDA for Versacloz™ from Jazz Pharmaceuticals, and upon closing of that transaction, appointed TruPharma as the exclusive distributor of Versacloz™. With this arrangement, TruPharma has expanded its platform to include distribution of branded pharmaceutical products through purchase and supply agreements with the three major wholesalers, other buying groups, and the federal government.